{"lead_paragraph": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "pub_date": "2016-01-14T00:00:00Z", "slideshow_credits": null, "byline": {"person": [{"lastname": "POLLACK", "role": "reported", "rank": 1, "organization": "", "firstname": "Andrew"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "section_name": "Business Day", "snippet": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "multimedia": [{"subtype": "wide", "width": 190, "height": 126, "type": "image", "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "legacy": {"wide": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}}, {"subtype": "xlarge", "width": 600, "height": 398, "type": "image", "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg", "legacy": {"xlargeheight": "398", "xlarge": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg", "xlargewidth": "600"}}, {"subtype": "thumbnail", "width": 75, "height": 75, "type": "image", "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}}], "blog": [], "type_of_material": "News", "headline": {"main": "Hemophilia Patient or Drug Seller? Dual Role Creates Ethical Quandary", "print_headline": "The Patient&#8217;s Sales Pitch "}, "keywords": [{"rank": "1", "name": "subject", "is_major": "Y", "value": "Hemophilia"}, {"rank": "11", "name": "organizations", "is_major": "N", "value": "Novo Nordisk A/S"}, {"rank": "12", "name": "organizations", "is_major": "N", "value": "Baxalta Inc."}, {"rank": "2", "name": "subject", "is_major": "Y", "value": "Drugs (Pharmaceuticals)"}, {"rank": "3", "name": "subject", "is_major": "Y", "value": "Conflicts of Interest"}, {"rank": "4", "name": "subject", "is_major": "N", "value": "Blood"}, {"rank": "5", "name": "subject", "is_major": "N", "value": "Ethics and Official Misconduct"}, {"rank": "6", "name": "organizations", "is_major": "N", "value": "Hemophilia of North Carolina"}, {"rank": "7", "name": "organizations", "is_major": "N", "value": "National Hemophilia Foundation"}, {"rank": "8", "name": "organizations", "is_major": "N", "value": "MedfusionRx LLC"}, {"rank": "9", "name": "organizations", "is_major": "N", "value": "Bayer AG"}, {"rank": "10", "name": "organizations", "is_major": "N", "value": "Pfizer Inc"}], "web_url": "http://www.nytimes.com/2016/01/14/business/hemophilia-patient-or-drug-seller-dual-role-creates-ethical-quandary.html", "print_page": "1", "source": "The New York Times", "news_desk": "Business", "abstract": "Increasing number of hemophilia drug makers and specialty pharmacies are employing patients and their relatives to gain sales advantage and increase revenue; ethical issues are raised. ", "word_count": "1254", "_id": "569694b938f0d865e6c34836", "subsection_name": null}